NEXGEL, Inc. (NXGL)
NASDAQ: NXGL · Real-Time Price · USD
2.550
-0.020 (-0.78%)
At close: Jun 17, 2025, 4:00 PM
2.500
-0.050 (-1.96%)
After-hours: Jun 17, 2025, 4:04 PM EDT
NEXGEL Market Cap
NEXGEL has a market cap or net worth of $19.52 million as of June 17, 2025. Its market cap has increased by 52.15% in one year.
Market Cap
19.52M
Enterprise Value
21.18M
1-Year Change
52.15%
Ranking
Category
Stock Price
$2.55
Market Cap Chart
Since the IPO on December 22, 2021, NEXGEL's market cap has decreased from $19.59M to $19.52M, a decrease of -0.36%. That is a compound annual growth rate of -0.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2025 | 19.67M | -41.33% |
| Dec 31, 2024 | 33.53M | 175.32% |
| Dec 29, 2023 | 12.18M | 74.85% |
| Dec 30, 2022 | 6.97M | -52.05% |
| Dec 31, 2021 | 14.52M | -25.85% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.57B |
| Johnson & Johnson | 377.99B |
| Novo Nordisk | 355.28B |
| AbbVie | 337.52B |
| Regencell Bioscience Holdings | 294.27B |
| UnitedHealth Group | 284.42B |
| Abbott Laboratories | 235.96B |
| Novartis AG | 234.52B |